公司核心定位与投资理念 - Allka Research是一家拥有超过20年投资经验的研究机构，专注于为个人投资者发掘高回报机会[1] - 该公司采用保守的投资方法，持续在ETF、大宗商品、科技和制药公司领域发现被低估的资产[1] - 其使命是通过Seeking Alpha平台分享知识，提供具有洞察力的分析和有见地的观点，帮助投资者简化投资策略[1] 分析师立场与利益关系 - 分析师声明在本文提及的任何公司中均未持有股票、期权或类似衍生品头寸，且未来72小时内无建立此类头寸的计划[2] - 该文章由分析师独立撰写，仅代表个人观点，除Seeking Alpha外未收取任何报酬[2] - 分析师与本文提及的任何公司股票不存在业务关系[2]

Downgrade to Underweight: Long-Term FCF Generation and Path to 4.0x Leverage Remain Elusive Following yet another disappointing quarter, marked by a slower wave-installation pace and softer revenue and EBITDA, we are downgrading Cogent to Underweight (from Neutral) and establishing a December 2027 price target of $9 (versus our prior December 2026 target of $22). Our Underweight rating is based on (1) continued top-line pressure, driven in part by the runoff of legacy Sprint contracts; (2) execution concern ...